62
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Autoantibodies in glaucoma

, &
Pages 113-116 | Published online: 02 Jul 2009

References

  • Wax MB, Barrett DA, Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1994; 117:561–568.
  • Wax MB, Tezel G, Edward PD. Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma. Arch Ophthalmol. 1998;116:993–1001.
  • Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol. 1999;117:917–924.
  • Romano C, Barrett DA, Li Z, Pestronk A, Wax MB. Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest Ophthalmol Vis Sci. 1995;36: 1968–1975.
  • Wax MB, Tezel G, Saito I et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1998;125:145–157.
  • Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2277–2287.
  • Yang J, Tezel G, Patil RV, Romano C, Wax MB. Serum autoantibody against glutathione 5-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci. 2001 ;42: 1273–1276.
  • Maruyama I, Ohguro H, Ikeda Y. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci. 2000;41:1657–1665.
  • Yang J, Patil RV, Yu H, Gordon M, Wax MB. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol. 2001;131: 421–426.
  • Schwartz M, Kipnis J. Protective autoimmunity: Regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med. 2001;7:252–258.
  • Yoles E, Hauben E, Palgi 0 etal. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001;21:3740–3748.
  • Romano C, Li Z, Arendt A, Hargrave PA, Wax MB. Epitope mapping of anti-rhodopsin antibodies from patients with normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1275–1280.
  • Young DB. Heat-shock proteins: Immunity and autoimmu-nity. Curr Opin Immunol. 1992;4:396–400.
  • Tezel G, Wax MB. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 2000;20:3552–3562.
  • Wax MB, Tezel G, Kawase K, Kitazawa Y. Serum Autoan-tibodies to Heat Shock Proteins in Glaucoma Patients from Japan and the United States. Ophthalmology. 2001;108(2): 296–302.
  • Ellis RJ. The molecular chaperone concept. Semin Cell Biol. 1990;1:1–9.
  • Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell. 1991;66:191–197.
  • Tezel G, Hernandez MR, Wax MB. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol. 2000;118:511–518.
  • Schumer RA, Podos SM. The nerve of glaucoma Arch Ophthalmol. 1994;112:37–44.
  • Gregerson DS. Immune privilege in the retina. Ocul Immunol Inflamm. 1998;6:257–267.
  • Becher B, Prat A, Antel JP Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia. 2000;29:293–304.
  • Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol. 1999;117:1050–1056.
  • Yang J, Yang P, Tezel G, Patil RV, Hernandez MR, Wax MB. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci. 2001;42:365–371.
  • Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001; 64:523–532.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.